In this segment, Dr Luskin examines how patient-related factors influence treatment decisions in blastic plasmacytoid ...
Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been ...
EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, researchers at Stanford Medicine have found. Manipulating this pathway ...
Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy that block specific proteins from slowing the immune response. As a result, ...
The Warburg effect describes how cancer cells switch from oxidative phosphorylation to glycolysis even in oxygen-rich ...
A therapy based on messenger RNA (mRNA), a genetic material actively studied for vaccines and other applications, has turned ...
Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results